On a white board in his office earlier this year, Trump trade adviser Peter Navarro made a list of potential companies that could manufacture pharmaceuticals in the U.S. He separated them into three columns, one for each stage of the production process. Eastman Kodak Co. stood out, overlapping two of …
Read More »The Wall Street Journal: How the Kodak generic-drug ingredients deal developed, and why it fell apart: a snapshot
